CUSIP: 05360L403 | NYSE | Healthcare · Biotechnology | Micro Cap | 14 institutional holders
5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.
| Holder | Shares | % of Class | Change | Event Date | vs 13F |
|---|---|---|---|---|---|
| 13D/AFortress Biotech, Inc. | 439,955 | 13.4% | New 5%+ stake | Jan 2, 2026 | No 13F filer matched |
| Style | Turnover | Location | Filed | ||||
|---|---|---|---|---|---|---|---|
| 140,000 | $280.0K | 0.0% | Deep Value | Very High | Dallas, TX | 2025-02-14 | |
| 41,089 | $82.2K | 0.0% | Value | Very High | New York, NY | 2025-02-14 | |
| 7,920 | $15.8K | 0.0% | Core | Medium | Zurich, Switzerland | 2025-02-14 | |
| 3,096 | $6.2K | 0.0% | GARP | Very High | New York, NY | 2025-02-13 | |
| 500 | $1.0K | 0.0% | Core | Low | San Francisco, CA | 2025-02-13 | |
| 14 | $28 | 0.0% | Core | Low | Charlotte, NC | 2025-02-14 | |
| 9 | $18 | 0.0% | Agg Growth | Low | Tokyo, Mexico | 2025-02-06 | |
| 0 | $0 | 0.0% | Growth | Very Low | Birmingham, AL | 2025-02-13 |